Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis
- 1 May 1995
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 345 (8960), 1275-1277
- https://doi.org/10.1016/s0140-6736(95)90927-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Antimicrobial Resistance in BacteroidesClinical Infectious Diseases, 1993
- Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazoleJournal of Antimicrobial Chemotherapy, 1993
- Nitroimidazole drugs - action and resistance mechanisms II. Mechanisms of resistanceJournal of Antimicrobial Chemotherapy, 1993
- CarbapenemasesJournal of Antimicrobial Chemotherapy, 1992
- A silent carbapenemase gene in strains of Bacteroides fragilis can be expressed after a one-step mutationFEMS Microbiology Letters, 1992
- An investigation of -lactamases from clinical isolates of Bacteroides speciesJournal of Medical Microbiology, 1992
- The antimicrobial susceptibility patterns of the Barteroides fragilis group in the United States, 1987Journal of Antimicrobial Chemotherapy, 1990